Article Item

A Guide to Participation in Performance Year 2022

Dec 16, 2021

ASRA Pain Medicine

The Medicare Access and CHIP Reauthorization Act (MACRA) was signed into law April 2015, repealing the flawed sustainable growth rate (SGR) and establishing a two-track Quality Payment Program (QPP) that emphasizes Medicare’s transition to value-based payment and delivery. Under the QPP, eligible pain medicine practitioners are required to participate in the Merit-based Incentive Payment System (MIPS) or are considered a qualifying participant (QP) in an Advanced Alternative Payment Model (APM) and are exempt from MIPS reporting. With the QPP moving into its sixth year – the 2022 performance period – pain medicine practitioners should note important changes that impact participation.

Read the 2022 guide here.

Close Nav